Aimwell Partners (AIMN) announced on Monday that it has entered final-stage negotiations to acquire a healthcare-related intellectual property portfolio valued at ~$10M. – CEO John Morgan said the acquisition aligns with the companyâs goal of building a portfolio of strategic…
althcare assets that can create long-term shareholder value. – The deal remains subject to due diligence and final agreements. – Moreover, there’s no guarantee the deal will close, and the company plans to share more details on the IP portfolio and commercialization plans after final agreements are completed